
Benzinga Pro data, Acutus Medical (NASDAQ:AFIB) reported Q1 sales of $3.68 million. Earnings fell to a loss of $40.02 million, resulting in a 28.0% decrease from last quarter. Acutus Medical collected $4.36 million in revenue during Q4, but reported earnings showed a $31.26 million loss.